Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03272009 |
|
Recruitment Status :
Completed
First Posted : September 5, 2017
Last Update Posted : August 21, 2018
|
Sponsor:
Enyo Pharma
Collaborator:
CPR Pharma Services Pty Ltd, Australia
Information provided by (Responsible Party):
Enyo Pharma
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | July 30, 2018 |
| Actual Study Completion Date : | July 30, 2018 |